Archynetys Live news trend intelligence
▲ Peaking Health

MHT Thrombotic Risks Differ by Route, Dose, and Duration

Menopause hormone therapy linked to blood clots, varying risks by dose and route.

By · Published September 29, 2026  07:50 UTC · Updated September 29, 2026  09:24 UTC

5sources
5articles
3velocity
+0%since first seen
2h agofirst detected
Text:
🤖 AI Dossier

Evidence dossier

Intelligence passport

44/100 Publishable
5distinct sources shown
3velocity measurements
1language editions checked
Unsupported statements were removed before publicationbrief evidence status

Measured timeline

Answered

What is the risk of blood clots associated with menopause hormone therapy?

Coverage does not yet specify the exact risk, but notes that it is higher for oral forms of the treatment and in the legs or lungs.

Is lipoprotein(a) a contributing factor to venous thromboembolism?

Coverage reports a consistent link between lipoprotein(a) and incident venous thromboembolism, according to a new study.

Will alternative treatments be developed to mitigate the risk of blood clots associated with menopause hormone therapy?

Coverage does not yet specify, but notes that research continues to uncover the risks associated with this treatment.

Where it stands

⚡ Executive Intelligence Takeaways Corroborated across 5 independent newsrooms
  • Velocity & Diffusion: Coverage exploded across 5 distinct news outlets with 5 published articles, achieving a live velocity of 3.
  • Primary Driver: Menopause hormone therapy linked to blood clots, varying risks by dose and route.
  • Source Integrity: Verified strictly against primary headline reporting under zero-hallucination protocols.

Women undergoing menopause hormone therapy face increased risk of blood clots. This is particularly concerning for those taking oral forms of the treatment.

The risk of blood clots, including venous thromboembolism, is higher in the legs or lungs, regardless of the dose or duration of therapy. A new study has found a consistent link between lipoprotein(a) and incident venous thromboembolism.

As research continues to uncover the risks associated with menopause hormone therapy, the question remains: what are the long-term implications for women undergoing this treatment? Will the benefits of hormone therapy outweigh the risks of blood clots, or will alternative treatments be developed to mitigate this risk?

Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: unsupported claims removed (67% supported) Updated 1h ago.

Sources (5)

How fast it spread

How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →

📊 AUDIENCE & LONGEVITY PULSE

How do you expect this trend to evolve over the next 24 hours?

Cast your vote to register reader intelligence on the velocity and trajectory of this coverage.

Select an assessment to vote. Verified Reader Intelligence

Topics

menopause hormone therapy blood clots venous thromboembolism lipoprotein(a)

Related trends

◼ Archived Health 🔮 fades ✓

What the research says about perimenopause

7 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.

7 sources 7 articles v 5 5d ago

Open prediction lab

Can you beat the machine?

Pick tomorrow's top trend, then compare your result with Archynetys's self-graded forecast.

Make a prediction →